One woman says she was diagnosed with potential life -threatening pancreatitis less than two months after the Jab Mounsoo weight began.
Julie Bishop, 55, decided to buy the drug as part of £ 120 a month after tiring other ways to lose weight.
Mounjaro, the Tirzepatide brand, has become increasingly popular in the UK since the sales license and was available this week through GP in the NHS.
But despite the loss of two and a half rocks by taking seven weeks for eight weeks, Ms. Bispev was forced to stop after detecting acute pancreatitis. The condition is when the small limb, located behind the abdomen, becomes inflamed. This can lead to the contamination of the pancreas and lead to septic disease and body failure that can be fatal.
“I suddenly caused a severe pain around my stomach, and when it turned out that I couldn’t get it, I went to the local walk center,” the mental health worker said. IndependentHuman
“When I got there, they did an ECG (electrocardiogram), and when I told them I took Monjaro, they sent me to the hospital by taxi, which I had after blood testing,” he said.
“They said that I had to stop getting Monjaro because it could be transplanted. It was very worrying for me because it was really doing well.”
After her diagnosis on May 15, the bishop suffered two other pancreatic attacks that led to the hospital, and she is now waiting to understand the magnetic resonance imaging (MRI) to understand the amount of damage to her pancreas and any complications.
Doctors still cannot be sure that the pancreas is associated with mongaro use. Another possible cause can be large amounts of cholesterol in the body that can form bile stones by rapid weight loss and can block the pancreas and lead to pancreatitis.
His story is highlighted as a new report highlights a possible risk-related risk of taking the weight of GLP-1 and diabetes, including Mounsjaro.
Official statistics from the Drug and Health Supervisory Agency (MHRA) show that about 181 acute and chronic pancreatitis has been reported, which has been linked to Moussaro since its license, killing five people.
These figures are due to voluntary medical reports of side -by -side accidents, and the use of medication may have been with a random disease rather than responsible for it.
However, Ms. Bishop said more should be done to share the risks of drug use.
He bought Mount Mounta from an online retailer called Zava, who said he had asked him to post basic photos of his body and answer questions about his medical history before sending drugs.
He said he was worried that the company, which collaborates with ASDA in the UK, did not respond to its message that he warned them more than a month ago.
“I know a lot of people who get it, so I wasn’t worried about using it at first,” he said.
“I think if people are explained that their limbs, like a pancreas, are important to the body, it will help and the damage that a side effect can cause,” he said.
“I’m tempted to go back to it, but only through the NHS. I think these drugs should only come to the people through the NHS, potentially, though they pay for it because of the dangers of it.”
On the Zava website, three steps for weight loss consulting to obtain Jabs are a “fast and simple” medical questionnaire, a preferential treatment and a physician examination.
Under the long -term “rare” side effects mentioned, it contains pancreatitis for Mounjaro.
From this week, people can also receive the drug from a general practitioner if they have a BMI of 40 or higher, and one of the five conditions that include type 2 diabetes and hypertension. Ozempic and Wegovy Jabs are available in the NHS, but only after visiting a specialized weight management service.
Earlier this month, NHS, Professor Sir Stephen Pavis, said weight loss Jabs could become the most common drugs, as it is estimated that 1.5 million people are now taking them in the UK.
As part of the fight against obesity, he welcomed Monjaro in GP surgeries and claimed that they could be available in pharmacies one day.
But he also warned that medications could be harmful if prescribed without proper checks and packaging care.
“They can have side effects, including nausea, dehydration and pancreatic inflammation, and the worrying number of people still have access to them without proper internet investigations,” he said.
Dr. Zone Andrew, Zawa’s chief medical director, said she could not discuss Ms. Bishop’s case because of the patient’s confidentiality. “We take the health of our patients very seriously and we are proud of the way we treat them,” he said.
“We know that pancreatitis can be one of the side effects of weight loss drugs. We do not prescribe this medicine for someone with pancreatitis. We respond to all messages that need medical care to support us.”
A spokesman for Lily, which Mounjaro, said that a patient pamphlet has warned that an inflamed pancreas is an unusual side effect and affects 100 people in 100 people. “We encourage patients to consult with a physician or other health care professionals about any side effects that may experience and make sure they are taking a real lily medicine,” they added.
